美国毒物控制中心报告的儿童ADHD药物暴露特征与趋势
报告暴露率2000至2011年上升71.2%,2011至2014年下降6.2%。治疗差错最常见,青少年中故意暴露(含疑似自杀和滥用)占该年龄组50.2%。
要点
- 报告暴露率2000至2011年上升71.2%,2011至2014年下降6.2%。
- 青少年(13-19岁)中故意暴露占50.2%,包括疑似自杀和药物滥用/误用。
核心结论
- 儿童ADHD药物暴露在美国呈增加趋势,影响所有年龄段儿童,青少年故意暴露尤其值得关注。
研究设计与样本
- 回顾性分析美国国家毒物数据系统2000至2014年数据,纳入0至19岁ADHD药物暴露报告。
主要发现
- 报告暴露率2000至2011年上升71.2%,2011至2014年下降6.2%。
- 76.0%的暴露涉及≤12岁儿童。
- 哌甲酯和安非他明类药物分别占暴露的46.2%和44.5%。
- 最常见的暴露原因为治疗差错(41.6%);青少年中故意暴露占50.2%。
临床怎么用
- 儿科医生应关注ADHD药物暴露风险,尤其对≤12岁儿童的治疗差错和青少年的故意暴露进行预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: : media-1vid110.1542/5754332180001PEDS-VA_2017-3872Video Abstract OBJECTIVES: To describe the characteristics and trends of exposures to attention-deficit/hyperactivity disorder (ADHD) medications among individuals 0 to 19 years old reported to US poison control centers. METHODS: National Poison Data System data from 2000 through 2014 were retrospectively analyzed to examine pediatric ADHD medication exposures. RESULTS: From 2000 through 2014, there were 156 365 exposures reported to US poison control centers related to ADHD medications. The overall rate of reported exposures increased 71.2% from 2000 to 2011, followed by a 6.2% decrease from 2011 to 2014. Three-fourths (76.0%) of exposures involved children ≤12 years old. Methylphenidate and amphetamine medications accounted for 46.2% and 44.5% of exposures, respectively. The most common reason for exposure was therapeutic error (41.6%). Intentional medication exposures (including suspected suicide and medication abuse and/or misuse) were reported most often among adolescents (13-19 years old), accounting for 50.2% of exposures in this age group. Overall, the majority of exposed individuals (60.4%) did not receive health care facility treatment; however, 6.2% were admitted to a hospital for medical treatment, and there were 3 deaths. The increasing number and rate of reported ADHD medication exposures during the study period is consistent with increasing trends in ADHD diagnosis and medication prescribing. Exposures associated with suspected suicide or medication abuse and/or misuse among adolescents are of particular concern. CONCLUSIONS: Unintentional and intentional pediatric exposures to ADHD medications are an increasing problem in the United States, affecting children of all ages.
引用
- King SA, Casavant MJ, Spiller HA, et al. Pediatric ADHD Medication Exposures Reported to US Poison Control Centers. Pediatrics. 2018. PMID: 29784754. doi:10.1542/peds.2017-3872
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。